Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations |
Autore | Ruaro Barbara |
Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
Descrizione fisica | 1 electronic resource (178 p.) |
Soggetto topico |
Medicine
Pharmacology |
Soggetto non controllato |
systemic sclerosis
scleroderma interstitial lung disease pulmonary function tests high-resolution computed tomography rheumatic pulmonary arterial hypertension targeted therapy systemic lupus erythematosus airway disease shrinking lung syndrome diffuse alveolar hemorrhage pleurisy infection cardiopulmonary exercise testing osteopontin connective tissue diseases pulmonary involvement microvascular involvement nailfold capillaroscopy rheumatoid arthritis interstitial lung diseases CX3CL1/fractalkine CX3CR1 M1 macrophage M2 macrophage SKG mice heart failure 3D-echocardiography ventricular function outcome ventricular-arterial coupling antifibrotic agents COVID-19 IPF progressive fibrosing ILD UIP pharmacological interactions fibromyalgia gastrointestinal symptoms probiotic VSL#3® efficacy tolerability polymyalgia rheumatica vagus nerve stimulation inflammatory response PMR t-vns |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Rheumatic Diseases |
Record Nr. | UNINA-9910566486303321 |
Ruaro Barbara
![]() |
||
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Rheumatoid Arthritis Therapy Reappraisal : Strategies, Opportunities and Challenges |
Autore | Müller Rüdiger |
Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
Descrizione fisica | 1 electronic resource (260 p.) |
Soggetto topico | Medicine |
Soggetto non controllato |
rheumatoid arthritis
sleep sleep disorders pain osteoporosis fracture fracture risk assessment tool treat-to-target certolizumab pegol csDMARDs glucocorticoids intra-articular injections DAS 28 ACR response HAQ-DI TNFα golimumab efficacy tolerability immunogenicity methotrexate posology titration oral route subcutaneous route bioavailability effectiveness periodontitis periodontal disease anti-citrullinated protein autoantibodies rheumatoid factor smoking medication Porphyromonas gingivalis Rheumatoid arthritis matrix metalloproteinase 3 infliximab pharmacogenomics anti-TNF personalized medicine baricitinib disease-modifying antirheumatic drugs pain perception outcomes research patient perspective Rheumatoid Arthritis therapy DMARD MTX Tumor Necrosis Factor-Alpha Inhibitors ankylosing spondylitis biosimilar switching synovial fibroblasts cytokine osteoclast herbal medicine methylation next-generation sequencing recovery of function fatigue productivity tofacitinib oral Th1.17 IL-17A IFN-γ, CD73 adenosine psoriatic arthritis regulation pseudoerosions hand foot ultrasonography radiography computed tomography magnetic resonance imaging |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Rheumatoid Arthritis Therapy Reappraisal |
Record Nr. | UNINA-9910557286503321 |
Müller Rüdiger
![]() |
||
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|